Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.

DOI:10.1016/S1470-2045(21)00073-5
作者：Andrés Poveda,?Anne Floquet,?Jonathan A Ledermann,?Rebecca Asher,?Richard T Penson,?Amit M Oza,?Jacob Korach,?Tomasz Huzarski,?Sandro Pignata,?Michael Friedlander,?Alessandra Baldoni,?Tjoung-Won Park
文献类型：期刊论文
补充材料：只需要正文